Información del producto
GSK J2 is a substance that inhibits the activity of histone methyltransferase enzymes. This drug has been shown to inhibit tumor growth and induce apoptosis in cancer cells. GSK J2 also increases insulin sensitivity, which may be due to its ability to suppress the production of Th17 cells. GSK J2 has been shown to improve insulin sensitivity in patients with type 2 diabetes. GSK J2 is an inhibitor of Hdac, a class of enzymes that regulate epigenetic gene expression. It has been shown to inhibit the growth factor-induced phosphorylation and activation of Akt/mTORC1 signaling pathway, which leads to decreased cell proliferation and increased apoptosis in mammalian cells.
Propiedades químicas
Consulta técnica sobre: 3D-UFC85452 GSK J2
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
